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Abstract There is a lack of comprehensive studies docu-
menting the impact of sample collection conditions on
metabolic composition of human urine. To address this issue,
two experiments were performed at a 3-month interval, in
which midstream urine samples from healthy individuals
were collected, pooled, divided into several aliquots and kept
under specific conditions (room temperature, 4 C, with or
without preservative) up to 72 h before storage at -80 C.
Samples were analyzed by high-performance liquid chro-
matography coupled to high-resolution mass spectrometry
and bacterial contamination was monitored by turbidimetry.
Multivariate analyses showed that urinary metabolic fin-
gerprints were affected by the presence of preservatives and
also by storage at room temperature from 24 to 72 h,whereas
no changewas observed for urine samples stored at 4 Cover
a 72-h period. Investigations were then focused on 280
metabolites previously identified in urine: 19 of them were
impacted by the kind of sample collection protocol in both
experiments, including 12 metabolites affected by bacterial
contamination and 7 exhibiting poor chemical stability.
Finally, our results emphasize that the use of preservative
prevents bacterial overgrowth, but does not avoid metabolite
instability in solution, whereas storage at 4 C inhibits bac-
terial overgrowth at least over a 72-h period and slows the
chemical degradation process. Consequently, and for further
LC/MS analyses, human urine samples should be kept at
4 C if their collection is performed over 24 h.
Keywords Metabolomics  Human urine  Stability 
High resolution mass spectrometry
1 Introduction
Metabolomics deals with the comprehensive analysis of
metabolites present in a biological sample by the combined
use of analytical methods and statistical analysis. The
metabolic fingerprints from tissues or biofluids contain a
few hundred to thousands of signals which are related to
both genetic and environmental contributions (e.g., life-
style, gut microbial activity, or exposure to xenobiotics)
(Holmes et al. 2008). Metabolomics investigates profile
changes in metabolites that reflect variations in metabolism
and may provide information regarding pathological state,
drug exposure, or biological stress. Metabolome analysis
can be done on various tissue or biofluid extracts depend-
ing on the kind of study. The use of urine samples is of
high interest, especially in clinical chemistry and
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toxicology, since its collection is non-invasive and con-
centrations of circulating metabolites are amplified by
bladder storage.
Urine is a complex biofluid that contains a variety of
different compounds such as amino acids, organic acids,
lipids, sugars, hormones, peptides, xenobiotics and end
products of metabolism such as glucuronides and sulfo-
conjugates (Bouatra et al. 2013). The comprehensive ana-
lysis of the human urine metabolome has mainly been
investigated by NMR, GC–MS and LC/MS (Ryan et al.
2011). Some reference protocols are available for these
three technologies (Beckonert et al. 2007; Chan et al. 2011;
Want et al. 2013) and some recommendations and standard
operating procedures for biobanking have also been pub-
lished (Barton et al. 2008; Bernini et al. 2011; Dunn et al.
2008).
One important point for metabolomics is the necessity to
maximize control of the experimental conditions and their
influence on metabolic fingerprints in order to avoid con-
founding factors that hamper biological interpretations of
results. Metabolite stability in biofluids is one of these
confounding factors. The stability of proteins and metab-
olites in human urine has already been investigated under
various sampling and storage conditions (Gika et al. 2007;
Gika et al. 2008; Lauridsen et al. 2007; Maher et al. 2007;
Saude and Sykes 2007; Thongboonkerd and Saetun 2007).
Long- and medium-term stabilities seem to be satisfactory
over a period of 6 months if the storage temperature is less
than or equal to -20 C (Gika et al. 2008; Lauridsen et al.
2007). Lauridsen et al. observed no change in the 1H-NMR
fingerprints of urine samples stored at -25 C for
26 weeks. They recommend storage of urine samples at
this temperature or below and showed that addition of
preserving agents is not mandatory in these conditions
(Lauridsen et al. 2007). Furthermore, two other studies
performed using NMR (Maher et al. 2007) and GC/MS
(Dunn et al. 2008) aimed at evaluating the impact of
sample collection and handling concluded that the effect of
storage is minimal compared with inter-individual varia-
tions of metabolite concentrations.
Whereas short-term stability of processed samples (i.e.,
centrifuged, diluted, etc.) before analysis is documented for
48 h at 4 C (and 24 h at room temperature), at least by
metabolomics and proteomics profiling and at the chemo-
metrical level (Gika et al. 2008; Thongboonkerd and Sae-
tun 2007), short- and medium-term stability of crude
samples at room temperatures is more problematic, espe-
cially in the course of urine collection over several hours
(24–48 h) (Maher et al. 2007; Saude and Sykes 2007).
It is during sample collection that bacterial overgrowth
is likely to be a matter of concern because it impacts on
concentrations of some metabolites (Lauridsen et al. 2007;
Maher et al. 2007; Saude and Sykes 2007) and also proteins
(Thongboonkerd and Saetun 2007). Indeed, bacterial
growth is very rapid and can modify urine composition by
consuming and producing metabolites. Although urine of
healthy subjects is supposed to be sterile, it can be con-
taminated through the urethra, which contains commensal
bacteria that may be carried by the urine stream (Maskell
2010). This explains why urine collection can be a critical
step in metabolomics studies and that sampling conditions
must be controlled.
The impact of bacterial overgrowth on the urine prote-
ome has been investigated with pooled normal urine by
evaluating different kinds of sample handling protocols
(i.e., temperature storage, centrifugation, addition of dif-
ferent concentrations of two preserving agents: sodium
azide and boric acid). Bacterial overgrowth was assessed
by UV–visible spectrophotometry and Gram staining; and
proteins were separated by 2D electrophoresis and detected
by MALDI-TOF-MS. After 48-hour storage at room tem-
perature without any preservative, the authors found more
than 500 newly presented protein spots, some of which
were identified by peptide mass fingerprinting. They con-
cluded that urine samples should be centrifuged and kept at
4 C, rather than at room temperature during the collection
interval. They also recommend the addition of 200 mM
boric acid or 10 mM sodium azide (Thongboonkerd and
Saetun 2007).
Concerning the urinary metabolome, most studies have
been performed using NMR (Lauridsen et al. 2007; Maher
et al. 2007; Saude and Sykes 2007). Increased concentrations
of glycine, creatine, benzoic, acetic, formic and lactic acids
were observed, together with decreased levels of creatinine,
and hippuric and citric acids. Regarding published studies
dealing with LC/MS-based approaches, they are mainly
qualitative and based on multivariate analysis of metabolo-
mics profiles or on visual comparison of spectra (Gika et al.
2007; Gika et al. 2008). This may be due in part to the
challenging issue of metabolite identification. Furthermore,
the use, in most cases, of individual urine samples hampers
the detection of metabolic concentration changes due to
stability issues because theymay be hidden by the huge inter-
individual variability usually observed in this biological
medium (Gika et al. 2007; Gika et al. 2008; Lauridsen et al.
2007; Maher et al. 2007; Saude and Sykes 2007).
In this context, the purpose of this study is to provide
comprehensive data about the short-term stability of
metabolites in human urine during sample collection. To
this end, two experiments were designed using pooled
urine samples which were subjected to different collection
protocols: storage at 4 C or at room temperature, with or
without preservatives over a 72-hour period. Bacterial
overgrowth was assessed by turbidimetry, and metabolo-
mics was achieved using ultra-high performance liquid
chromatography coupled to a high-resolution mass
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spectrometry (UHPLC/HRMS) method enabling the
detection and identification of a few hundred metabolites in
human urine (Roux et al. 2012).
2 Materials and methods
2.1 Chemicals
All reagents, chemicals and preservatives were from Sigma
(Saint Quentin Fallavier, France). The standard mixtures
used for the external calibration of the MS instrument
(Calmix-positive, for the positive-ionization mode, con-
sisting of caffeine, L-methionyl-arginyl-phenylalanyl-ala-
nine acetate, and Ultramark 1621; Calmix-negative, for the
negative-ionization mode, consisting of same mixture plus
sodium dodecyl sulfate and sodium taurocholate) were
from Thermo Fisher Scientific (Les Ulis, France). Aceto-
nitrile was from SDS (Peypin, France) and formic acid
from Merck (Briare-le-Canal, France). Water was deion-
ized and filtered through a Millipore Milli-Q water purifi-
cation system.
2.2 Biological material
Urine samples were anonymously collected from labora-
tory staff. Only the gender of the donor was recorded.
Samples were collected on the day of the experiment
between 9:30 and 10:30 a.m. (T0 = 10:30 a.m.). Two
experiments were conducted with different donors over a
period of 3 months, always using the same protocol
(Table 1). Once urine samples were pooled (to eliminate
inter-individual variations), several aliquots were prepared
and subjected to different collection conditions (with or
without preservatives) and were stored either at room
temperature (on the laboratory bench, with recorded tem-
peratures ranging from 19 to 26 C, as displayed in
Table 1) or at 4 C. Samples were collected at regular time
intervals (every 4 or 12 h) between 0 and 72 h and kept at
-80 C until analysis. Samples for UHPLC/HRMS ana-
lysis were centrifuged (3,000 rpm for 5 min) and then
diluted in deionized water (dilution 1/5:20 ll of urine in
80 ll of water) prior to analysis. For nuclear magnetic
resonance (NMR) analysis, urine samples were thawed,
and 0.4 mL of urine was added to 0.2 mL of phosphate
buffer in D2O (0.2 M, pH = 7.00) containing sodium
3-trimethylsilyl[2,2,3,3-2H4]propionate (TSP) (Sigma-
Aldrich, USA), and pH adjusted to 7.00 after a 20 min
delay. Urine was centrifuged to eliminate cellular frag-
ments and sediments, and 0.5 mL was transferred to a
5 mm NMR tube (New Era, USA).
2.3 Turbidimetry
The turbidity measurement was carried out on a plate
reader Multiskan EX from Thermo Fisher Scientific (Les
Ulis, France). Absorbances were measured at 620 nm.
2.4 UHPLC/HRMS-based metabolomics
2.4.1 Instrumental parameters
Analyses were performed on an Accela liquid chromato-
graphic system (Thermo Fisher Scientific) coupled to an
LTQ-Orbitrap Discovery (Thermo Fisher Scientific) fitted
with an electrospray source operated in the positive- and
negative-ion modes. The software interface was Xcalibur
(version 2.1) (Thermo Fisher Scientific). The mass spec-
trometer was calibrated before each analysis using a cali-
bration solution provided by the manufacturer (external
calibration). The UHPLC chromatographic separation was
performed on a Hypersil GOLD C18 1.9 lm,
2.1 9 150 mm2 column (Thermo Fisher Scientific) equip-
ped with an online prefilter (Interchim, Montluc¸on,
France). The mobile phases were (A) 100 % water and
(B) 100 % acetonitrile with 0.1 % formic acid. After an
isocratic step of 2 min at 100 % phase A, a linear gradient
from 0 to 100 % B was run over the next 11 min with a
mobile phase flow of 500 ll/min. After returning to 100 %
A at 15.5 min, the column was then allowed to equilibrate
for 3.5 min, leading to a total run time of 19 min.
Mass spectra were recorded from 75 to 1,000 Th with an
AGC value of 5 9 105. The mass resolution of the analyzer
was set to 30,000 (m/Dm, fwhm at 400 Th). The mass
spectra were acquired in the reduced profile mode. In the
positive-ion mode, the electrospray voltage was set to
5 kV, the capillary voltage to 8 V, and the tube lens offset
to 65 V. The sheath and auxiliary gas flows (both nitrogen)
Table 1 Experimental design. Collection conditions and time points for the two experiments are indicated as colored cells
Preservative 4°C RT 0 12 24 36 48 72
Exp. 1 July 2010 2 women3 men 26°C
23°C
Experiment Date Pool Collection conditions
Time point (h): T 0 = 0
Exp. 2 Sept. 2010 3 women2 men Boric acid (200 mM)
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were optimized at 35 and 8 arbitrary units (au), respec-
tively, and the drying gas temperature was set to 275 C. In
the negative-ion mode, the electrospray voltage was set to
-3.5 kV, and the capillary voltage and tube lens offset
were set to -20 and -70 V, respectively; the sheath and
auxiliary gas flows (both nitrogen) were 45 and 15 au
respectively, and the drying gas temperature was 275 C.
Biological samples were randomly analyzed and a
quality control sample (QC: urine pool) was injected every
10 samples to check the performance of the analytical
system in terms of retention times, accurate mass mea-
surements, and signal intensities. All raw data and associ-
ated metadata are publically available on the MetaboLights
repository (MTBLS148).
2.4.2 Data processing
Automatic peak detection and integration were performed
using XCMS software package (Smith et al. 2006). Raw files
werepreliminarily converted tonetCDFformatwithXconvert
(Thermo Scientific, Les Ulis, France). Data were processed
using XCMS version 1.14.1 running under R version 2.8.1.
The R language was installed on a Dell Eight-core Intel Xeon
3.00 GHz Processor with 16GoRAM running Linux (Centos
5.2 x86_64). The matchedFilter algorithm was used and
default values were set for all parameters except for fwhm,
step, steps, mzdiff, and mzwid, which were set respectively at
4, 0.01, 2, 0.01, and 0.01 (for both grouping steps).
2.4.3 Intensity drift correction
Intensities of the 4 peak lists (2 experiments 9 2 ionization
modes) were normalized as follows. First, for each variable, a
local quadratic (loess) model representative of intensity var-
iation along passage order was built with the values of the QC
sample (Dunn et al. 2011). Intensitieswere then divided by the
model predictions. For the positive peak list of Exp. 2, QC
values were not representative, and variable intensities were
divided by their median as no obvious drift was observed.
Second, peak list intensities were scaled by multiplying each
of the four blocks by a common factor equal to the geometric
mean of the block raw intensity medians. Note that this last
step is only aimed at providing intensities with meaningful
values (otherwise relative intensities are close to 1) and does
not modify univariate statistics (since nonparametric tests are
used) nor multivariate modeling (because of unit-variance
scaling). Normalization resulted in a decrease from the
median of the coefficient of variation (CV) of the identified
variables (see below) within the QC samples in Exp. 1 (resp.
Exp. 2) from 24 to 5 % (resp. from 14 to 11 %). The few
variables that remained correlated with injection order (\5
and 2 % for Exp. 1 and Exp. 2, respectively) were discarded.
2.4.4 Filtering
Variables with a mean intensity in the QC samples less
than two times the mean intensity in blank samples (i.e.,
phase A: water with 0.1 % formic acid), or with a CV in
the QC samples[30 % were filtered out.
2.4.5 Statistical analysis
Univariate correlation with time storage duration was
tested by using the nonparametric Spearman coefficient
of rank correlation (Kvam and Vidakovic 2007) and
controlling the false discovery rate (Benjamini and
Hochberg 1995) at a 0.01 threshold. All peak intensities
of the metabolites showing significant variations were
confirmed by manual integration using the QuanBrowser
software, in order to avoid any false-positive or false-
negative deconvolution that may have been generated
with XCMS.
Prior to multivariate analysis, one observation from
Exp. 2 with outlier distribution quantiles (Alonso et al.
2011) (p = 10-3 threshold) was discarded. Intensities were
log10 transformed and variables were mean-centered and
unit-variance scaled, prior to principal component analysis
(PCA) and partial least-squares (PLS) analysis with two
components (with the storage duration as Y response). To
assess the predictive performance of each PLS-DA model,
cross-validation was used to compute the diagnostic Q2
value (Wold et al. 2001). The statistical significance of Q2
was estimated by permutation testing (Szymanska et al.
2012): the Q2 value was compared to the distribution of 103
Q2 values corresponding to models built after random
permutation of the response labels.
Normalization, univariate and multivariate statistical
analyzes were all performed using scripts coded and run in
the R language and environment (R Core Team, 2013;
version 3.0.2). Venn diagrams were drawn using the
‘‘Vennerable’’ package version 1.0 (Swinton 2009).
2.4.6 Metabolite identification
Metabolites were identified by taking into account the
metabolomics standard initiative (MSI) criteria (Sumner
et al. 2007) and by using a spectral database developed in
our laboratory (Roux et al. 2012). UHPLC/HRMS-peak-
lists generated by XCMS were annotated using an in-
house software tool that matches masses (within a 5 ppm
range) and retention times of ions of biological datasets
with those of reference compounds contained in the
spectral database.
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2.5 NMR
2.5.1 Recording of NMR spectra from human urine
Proton NMR (1H NMR) spectra were acquired with a
Bruker Avance-500SB (Bruker, Wissembourg, France)
operating at 500.13 MHz and equipped with a 5 mm
broadband inverse probe with non-spinning samples and
thermostated at 298 K. Spectra were collected into 32 K
points with a spectral width of 5,000 Hz (10 ppm).
Acquisition of the spectra was performed with a presatu-
ration of the water signal during 2 s after a relaxation delay
of 8 s. A total of 128 transients were accumulated for a
total acquisition time of 28 min and 24 s. Spectra were
phased, baseline corrected, and referenced to TSP manu-
ally with the XWIN-NMR software (version 3.5, Bruker,
Karlsruhe, Germany).
2.5.2 Processing of NMR data
For PCA, spectra were transformed into a table of buckets
of size 0.02 ppm with the AMIX software (Version 3.9.7;
Bruker Biospin, Germany). PCA were performed with the
SIMCA-P software (version 11.0.0.0; Umetrics, Sweden).
The spectral region from 4.50–5.50 ppm was excluded to
remove variability due to suppression of the water resonance
signal. Each bucket was divided by the total integral of all
individual regions to normalize the urine dilution between
individual samples. Spectral regions were investigated to
identify the discriminating metabolites. Spectra were pro-
cessed and analyzed with MestReNova sofware (version
6.2.0, Mesrelab, Santiago di compostella, spain). Spectra
were obtained after a Fourier transformation without apodi-
zation. After phase correction and baseline correction, peak
areas were measured by line fitting. Concentrations of mole-
cules were obtained using TSP as quantitative reference.
2.5.3 Metabolite identification
Identification of the metabolites was performed using the
Human Metabolome Database (Wishart et al. 2007).
3 Results and discussion
3.1 Bacterial overgrowth
Initial bacterial contamination of urine occurs during col-
lection. Whereas the bladder urine is sterile in the absence
of infection, skin commensal flora (e.g. bacteria of the
Staphylococcus and Corynebacterium genera), but also
bacteria of the gastrointestinal tract (Escherichia, Klebsi-
ella, Proteus, Enterococcus genera), can be found at the
urethral meatus and perineum (Maskell 2010). Conse-
quently, control of bacterial growth during and after urine
collection is mandatory.
Although some variability in bacterial growth was
observed at room temperature between the two experi-
ments (Fig. 1), the largest differences occurred within each
experiment, according to the experimental factors studied
(storage temperature, addition of a preservative). Optical
density remained low for all the samples kept at 4 C. In
contrast, bacterial growth increased dramatically at room
temperature (i.e., 26 C and 23 C for experiment 1,
Exp. 1, and experiment 2, Exp. 2, respectively). Such
contamination was prevented by adding boric acid pre-
servative to those samples (Fig. 1).
3.2 LC–MS metabolomics analysis of concentration
variations induced by urine collection and storage
conditions
Preprocessing of the raw LC–MS files (XCMS peak
detection and retention time alignment, followed by nor-
malization and QC filtering; see the experimental section
for detailed information) resulted in 4 peak Tables (2
experiments 9 2 ionization modes) with a number of fea-
tures ranging from 1,476 to 4,164, which were further
analyzed by unsupervised and supervised multivariate
modeling.
Unsupervised (PCA) and supervised (PLS) multivariate
analyses of the whole datasets were performed, respec-
tively, in order to have an overview of the overall vari-
ability, and to look for specific trends according to
collection condition and storage duration. Exp. 2 was ana-
lyzed first because it exhibited the highest bacterial growth
(Fig. 1) and because it included the 3 collection conditions:
(i) with preservative at room temperature (Pres), (ii) with-
out preservative at room temperature (RT) and (iii) without
preservative at 4 C. Three clusters corresponding to each
storage condition can be clearly observed along the second
dimension of the principal component score plot modeling
the positive ion mode data (Fig. 2a), despite some spread
between replicates which may be due to technical vari-
ability during sample preparation and measurement. This
axis seems to be negatively correlated with bacterial growth
since samples kept at room temperature had the most neg-
ative values, whereas the scores of urine stored at 4 C
remained close to 0. Interestingly, samples collected with a
preservative (200 mM boric acid) were grouped in a distinct
cluster, which could reflect the impact of boric acid on the
electrospray ionization yields in so far as no bacterial
overgrowth occurred in these samples. Taken together,
these results indicate that both the bacterial overgrowth and
Impact of collection conditions on the human urinary metabolome 1099
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the presence of preservative impact on the metabolic
composition of urine.
We further focused on the effects of the storage condi-
tions by using partial least-square analysis (PLS) (Wold
et al. 2001) (Fig. 2b). Remarkably, the time course evo-
lution of both RT and Pres samples were correlated with
the first bisector (although with a smaller variance for the
latter), but not the 4 C urines, suggesting that mechanisms
other than bacterial growth (e.g. chemical degradation)
impact on metabolite concentrations at room temperature.
The same trends were seen with the data recorded in the
negative ion mode of Exp. 2 (figure provided as supple-
mentary material 7) and also with the data obtained with
Exp. 1 (Fig. 2c, d). Only the negative mode of Exp. 1 did
not provide significant PLS modelling, suggesting that time
dependence may be masked by other sources of variability
in this particular dataset. In conclusion, a discrimination
between the samples stored at room temperature and those
stored at 4 C is evidenced in both experiments.
To further characterize the human urine metabolites
impacted by collection conditions, we focused on the
molecules that were identified by using our spectral data-
base, on the basis of accurate mass, chromatographic
retention times and MS/MS (Roux et al. 2012). Multivar-
iate analyses on these reduced datasets showed similar
patterns compared with the original data (figure provided
as supplementary material 8), suggesting that restriction to
identified metabolites did not introduce any major bias.
3.3 Identification of metabolites whose concentrations
are impacted by collection and storage conditions
We identified 184 and 232 metabolites in samples from
Exp. 1 and Exp. 2 respectively, including 136 that were
common to both experiments (Fig. 3a). Univariate corre-
lations between metabolite intensities and storage duration
(from 0 to 72 h) were tested for each condition: RT, 4 C,
and Pres (the peak tables with chemical and statistical
annotations are provided as supplementary materials 3 and
4).
We found 16 metabolites meeting the two criteria of
interest: correlation with storage duration in the RT sam-
ples, and identical statistical significance between the two
experiments (when available) in both the RT and 4 C
conditions (Fig. 3b). Three additional metabolites (i.e.,
threonolactone, and two isomers of hydroxyretinoic and
ketoretinoic acid glucuronides) were also included due to
their interesting concentration trends. Importantly, these
univariate selection results were confirmed by multivariate
PLS modeling (i.e., computation of ‘‘Variable Importance
in Projection’’, VIP): an average of 81 % identity between
the metabolites with the lowest p values and the highest
VIPs was obtained, and none of the few metabolites with
high VIP but not significant p value displayed variations
fully compatible with the robust selection criteria described
previously. The details of the molecule names, the varia-
tion trends and the first time point with concentrations all
above (or below, depending on the trend) T0 are reported in
Table 2. For the majority of the metabolites, the impact of
sample collection and storage conditions on urinary
metabolite concentrations was observed by 24 h (with
triplicate concentrations all higher, or lower, than at T0).
By comparing results between groups, two sources of
instability (i.e., bacterial overgrowth or chemical instabil-
ity) were found: a significant correlation only at RT indi-
cated an impact of bacterial overgrowth, whereas a
significant correlation at RT and 4 C, and/or with pre-
servative indicated chemical instability (Table 2).
Fig. 1 Bacterial growth
according to storage conditions.
The means and standard
deviations of the triplicate
optical density measurements
are plotted as solid (Exp. 1) or
dashed (Exp. 2) lines
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3.3.1 Changes in metabolite concentrations related
to bacterial overgrowth
According to previously published studies, some metabo-
lites detected by NMR have already been linked to
bacterial contamination (Lauridsen et al. 2007; Maher et al.
2007; Saude and Sykes 2007), but not in the same exper-
imental conditions as those reported in the present study.
Indeed, these studies addressed metabolite stability issues
related to either long-term storage for periods ranging from
Fig. 2 Impact of storage conditions on metabolite concentrations
analyzed by multivariate modeling. a and c Principal component
scores of the positive peak tables from Exp. 2 (a) and Exp. 1 (c) in the
first two dimensions. The individual (in parentheses) and cumulative
(ExpX) proportions of explained variance are indicated. The 95 %
ellipses corresponding to a multinormal distribution for each sample
condition are superimposed in color. b and d Scores resulting from
partial least-squares (PLS) modeling of the storage duration in Exp. 2
(b) and Exp. 1 (d). The cumulative proportion of explained variance
of the response (ExpY) and the estimation of the model predictive
performance by cross-validation (Q2) are shown. The statistical
significance of Q2 diagnostics was confirmed for all PLS models by
permutation testing (p\ 0.05; see supplementary material 9)
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Fig. 3 Number of metabolites
impacted by storage duration.
a Total number of identified
metabolites in Exp. 1 and
Exp. 2 which were used for
statistical analysis. b Number of
metabolites significantly
correlated with storage duration
at 4 C or at room temperature
with (Pres) or without (RT) a
preservative
Table 2 Effect of storage conditions on metabolite concentration variation over time.
cor time cor time cor time cor time cor time
Creatine IDa,c HMDB00064 pos 0.99 T12 ns ns 0.7 T48 ns ns ns ns
Trimethylamine oxide IDa,c HMDB00925 pos -0.98 T12 ns ns -0.92 T48 ns ns ns ns
2-hydroxy-3-Methylbutyric acid IDa,c HMDB00407 neg -0.98 T12 ns ns -0.84 T48 ns ns ns ns
Methylguanosine IDa,c,d HMDB05862 neg -0.96 T12 ns ns -0.81 T48 ns ns ns ns
Methylinosine Putative Aa,b
HMDB02721/H
MDB03950 pos -0.93 T12 ns ns -0.88 T48 ns ns ns ns
Glutamine IDa,b,c,d HMDB00641 pos -0.91 T12 ns ns -0.88 T48 ns ns ns ns
Dimethylguanosine Putative Aa,b HMDB04824 neg -0.86 T36 ns ns -0.71 T72 ns ns ns ns
Cholic acid IDa,c HMDB00619 neg 0.81 T12 ns ns 0.77 T12 ns ns ns ns
Valine IDa,c HMDB00883 pos 0.81 T12 ns ns 0.71 T48 ns ns ns ns
3-methyl-2-Oxovaleric acid IDa,c HMDB00491 neg -0.77 T12 ns ns -0.84 T48 ns ns ns ns
Aniline isomer Putative Ca pos 0.71 T12 ns ns 0.69 T48 ns ns ns ns
pos ns† T12 -0.88 T12 -0.91 T24 ns ns ns ns
neg ns† T12 -0.92 T12 -0.83 T24 ns ns ns ns
pos -0.93 T12 -0.81 T12 -0.97 T12 -0.96 T12 -0.93 T12
neg -0.99 T12 -0.81 T12 -0.98 T12 -0.93 T12 -0.95 T12
Urobilin Putative Aa,b HMDB04159 neg -0.99 T12 -0.75 T12 -0.98 T12 -0.89 T12 -0.91 T12
Ketoretinoic acid glucuronide isomer* Putative Ca,b neg -0.94 T36 ns ns -0.98 T12 -0.94 T24 -0.97 T12
Hydroxyretinoic acid glucuronide isomer* Putative Ca,b neg -0.91 T36 ns ns -0.95 T12 -0.86 T24 -0.98 T12
Ascorbic acid IDa,c,d HMDB00044 neg -0.88 T12 -0.76 T72 -0.96 T12 -0.91 T24 -0.98 T12
Threonolactone* Putative Aa,b HMDB00940 neg 0.79 T12 ns ns 0.94 T12 0.91 T12 0.98 T12
Orotic acid IDa,c,d HMDB00226 neg 0.66 T24 ns ns 0.88 T24 ns ns 0.72 T24
Variation
related toMetabolite
July 2010 (Exp. 1)
RT 4°C RT 4°C Pres































Metabolites whose concentrations were impacted by either bacterial metabolism or chemical instability were sorted by increasing corrected p-
values associated with correlation with room temperature, 4 C and preservative storage duration. Metabolites were identified according to the
metabolomics standard initiative (MSI) criteria (Sumner et al 2007)
cor The value of the spearman correlation coefficient when the FDR of the test is\0.01 (ns otherwise) is colored in green/red according to its
sign; time: first time point at which triplicate concentrations are all above (in case of positive correlation, below otherwise) the T0 triplicate
concentrations. ID: identified (i.e., level 1); Putative A: putatively annotated compound (i.e., level 2); Putative C: putatively characterized
compound (i.e., level 3)
a m/z matching structure
b MSn matching structure
c retention times (C18 and PFPP chromatography columns) matching standards (Roux, 2012)
d MSn matching standard
* Three metabolites, although not meeting all statistical criteria at the 0.01 threshold, were included in the table because of meaningful variation
trends, and are discussed in the results section
 The decrease of the N-acetylcytidine concentrations in Exp 1 is so abrupt (fall to 0 as soon as T12; see the graphics for N-acetylcytidine in the
supplementary information) that the correlation test fails to reflect this variation
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weeks (Saude and Sykes 2007) to months (Lauridsen et al.
2007; Maher et al. 2007), or short-term storage, but at
temperatures equal to or below ?4 C (Barton et al. 2008;
Maher et al. 2007). Regarding the 13 reported metabolites
linked to stability issues (i.e., acetic acid, benzoic acid,
creatine, creatinine, lactic acid, citric acid, hippuric acid,
succinic acid, malonic acid, formic acid, trimethylamine,
urea, alanine and glycine), 5 (i.e., creatine, creatinine,
lactic acid, citric acid, hippuric acid, and malonic acid)
were detected by our LC/MS method, and all of them
except for benzoic acid were detected by NMR. The con-
centration variations of these 13 metabolites are provided
as supplementary materials 1, 3 and 4. Of note, no other
metabolite was highlighted by multivariate statistical
analyses (PCA score plots of NMR results for both
experiments are provided as supplementary material 2).
Increased concentrations of creatine observed using LC/
MS and NMR were consistent with published NMR data
(Saude and Sykes 2007). We did not observe any increase
of creatinine or decrease of citric acid levels using either
Fig. 4 Metabolites whose concentrations are affected by bacterial
overgrowth or chemical instability. Metabolite intensities were
measured by LC–MS (n = 3) or NMR (acetic acid; n = 1). For each
storage condition, intensities were normalized relative to the (mean
of) T0 (triplicate) value(s). The (means of the) relative intensities are
plotted as solid lines for Exp. 1 and dashed lines for Exp. 2. In case of
triplicates, standard deviations are indicated as bars. For urobilino-
gen, the two curves for each condition correspond to the positive and
negative ionization modes
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LC/MS or NMR, contrary to what has been noted in long-
term stability studies using NMR experiments (Lauridsen
et al. 2007; Maher et al. 2007). No clear trend was
observed regarding malonic acid in our LC/MS and NMR
data. The reported increase of lactic acid in long-term
stability studies was only observed in Exp. 2 from LC/MS
data, whereas concentrations of this metabolite were
decreased in samples of Exp. 1 stored at room temperature
and analyzed using both LC/MS and NMR. Finally, no
significant variation was observed in our LC/MS conditions
for hippuric acid, whereas concentrations increased by a
factor of 1.5 were measured by NMR in those samples of
Exp. 2 that were stored at 4 C. Lastly, from our NMR
data, increased concentrations of acetic acid were observed
in both experiments (Fig. 4; consistent with published
NMR data from long-term stability studies) whereas the
levels of glycine, alanine and trimethylamine were not
altered (the time courses of metabolites monitored by NMR
are provided as supplementary material 1).
Furthermore, 11 metabolites whose variations related to
bacterial contamination had not been described previously
were observed in our LC/MS data sets: trimethylamine
oxide, 2-hydroxy-3-methylbutyric acid, methylguanosine,
methylinosine, glutamine, dimethylguanosine, cholic acid,
valine, 3-methyl-2-oxovaleric acid, an isomer of aniline, and
N-acetylcytidine (Table 2; Figure 4, and graphs provided as
supplementary material 6). Some of these variations may be
easily explained by bacterial fermentation, as is, for exam-
ple, the case with sugar derivatives, amino acids and
nucleoside derivatives (Janssens et al. 2014). In addition,
decreased concentrations of trimethylamine oxide (TMAO;
Fig. 4), which were also observed in NMR measurements,
may be linked to bacterial overgrowth since this compound
is involved in the metabolism of microorganisms.
Interestingly, concentration variations of most of these
metabolites were detected from 12 h in Exp. 1, and rather
at 48 h in Exp. 2. This can be explained by the differences
of bacterial overgrowth kinetics observed between the two
experiments: bacterial overgrowth can be observed from
12 h in Exp. 1 whereas it is delayed in Exp. 2 (Fig. 1).
3.3.2 Variations related to chemical stability
Seven metabolites exhibited changes in concentrations
both at room temperature (without preservative) and with
preservative or at 4 C: urobilinogen, urobilin, ascorbic
acid, orotic acid, in addition to isomers of ketoretinoic acid
and hydroxyretinoic acid glucuronides, and threonolactone
(Table 2; Figure 4, and graphs provided as supplementary
material 6). The three latter metabolites were included into
the list because, although the correlation significances at
4 C differed between Exp. 1 and Exp. 2 at the 0.01 FDR
threshold, the trends were similar. As no bacterial
contamination was observed with preservative or at 4 C,
these variations cannot be explained by bacterial over-
growth, but rather by chemical instability in solution.
Concentration variations were more extreme in RT condi-
tions than at 4 C, as observed for the decrease of ascorbic
acid levels (Fig. 4). The latter was confirmed by increases
in concentration of threonolactone, the autoxidation prod-
uct of ascorbic acid, in both RT and Pres samples (Fig. 4).
4 Concluding remarks
We highlighted here the metabolic consequences of bac-
terial contamination of urine samples, and also the chem-
ical instability of some metabolites. Among the 280
detected metabolites, 19 (i.e. 7 %) showed robust signifi-
cant changes in concentration according to storage condi-
tions, whether due to bacterial contamination (12/19) or
chemical instability in solution (7/19). In addition to
metabolites already known to be affected by bacterial
overgrowth, such as creatine and acetic acid, other
metabolites were shown to be impacted by bacterial
metabolism, such as those related to the metabolism of
nucleosides, amino acids, or choline. Chemical instability
in solution was observed to a lesser extent, and was also
highly correlated with the storage temperature.
Sampling conditions therefore have an impact on the
chemical composition of urine. Most changes occur at room
temperature from 12 h onwards and are depending on
kinetics of bacterial overgrowth. Preservatives are effective
in preventing bacterial contamination, but not in avoiding
chemical instability, contrary to collection on ice which both
prevents bacterial growth and limits metabolite degradation.
Our results obtained on human urine are consistent with GC/
MS data on rodent urine (Bando et al. 2010) showing that
collection in metabolism cages at 4 C limits changes in
metabolite content of urine samples and demonstrate that
collection on ice is the most effective sampling condition.
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